This bill matters because it aims to speed up the process by which new over-the-counter (OTC) drugs and ingredients become available to the public. Currently, companies seeking to introduce new OTC options sometimes face lengthy and unclear approval processes. By requiring the FDA to use the "least burdensome appropriate means" and provide clear guidance through mandatory meetings, the bill could help get innovative self-care solutions onto store shelves more quickly.

If this bill becomes law, consumers might see a wider range of OTC products available sooner, potentially at lower costs due to reduced development hurdles for manufacturers. If it doesn't become law, the current review process for OTC monograph drugs, which some argue can be slow and opaque, would remain unchanged, potentially delaying access to new medications and innovations in self-care.